Cytokines, chemokines, complement components, and autoantibodies

This entry describes a heterogeneous group of immunological mediators and effectors rather than a single molecular target. Cytokines and chemokines are small signaling proteins essential for cell-to-cell communication, regulating immune cell activation, differentiation, and chemotaxis in response to stimuli (StatPearls, 2023). The complement system consists of a series of plasma proteins that enhance the ability of antibodies and phagocytic cells to clear microbes and damaged cells (NIH, 2022). Autoantibodies are immunoglobulins produced by the B-cell lineage that target self-antigens, leading to tissue damage in various autoimmune conditions (Nature Reviews Rheumatology, 2020). While individual members of these classes—such as Tumor Necrosis Factor-alpha or Complement Component 5—are validated therapeutic targets, the collective grouping is too broad for specific drug development profiling. Pharmacological strategies targeting these components include monoclonal antibodies, decoy receptors, and small molecule inhibitors aimed at modulating aberrant immune signaling and inflammation.

Other names

Inflammatory mediatorsImmune system componentsHumoral immune factorsSoluble immune mediators

Neutralization of soluble factors, blockade of surface receptors, depletion of specific protein components, or inhibition of autoantibody-producing cells.